Paul Goldsmith

Title: Paul Goldsmith: Innovator in Medical Treatments

Introduction

Paul Goldsmith is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medicine, particularly in the treatment of sialorrhoea. With a total of 2 patents to his name, Goldsmith's work has the potential to improve the quality of life for many patients.

Latest Patents

Goldsmith's latest patents focus on the combination of an alpha-2 receptor agonist, specifically clonidine, and an anti-muscarinic agent, oxybutynin, for the treatment of sialorrhoea. This innovative approach utilizes an alpha2 adrenoreceptor agonist, such as clonidine, brimonidine, monoxidine, or lofexidine, which is administered through paraungual, sublingual, or buccal routes. The treatment plan also includes the administration of an anti-muscarinic agent like oxybutynin, glycopyrrolate, or ipratropium to enhance efficacy.

Career Highlights

Goldsmith is currently associated with Orient Pharma (Samoa) Co., Ltd., where he continues to develop and refine his medical inventions. His dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

One of his notable collaborators is Alan Geoffrey Roach, with whom he has worked closely to advance their shared goals in medical research and development.

Conclusion

Paul Goldsmith's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving patient care. His work in developing effective treatments for sialorrhoea showcases the importance of collaboration and innovation in the medical field.